In-hospital outcomes of thrombolysis for acute ischemic stroke in patients with primary brain tumors
- 1 March 2015
- journal article
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 22 (3) , 474-478
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Thrombolysis for Ischemic Stroke in Patients with Brain TumorsJournal of Stroke and Cerebrovascular Diseases, 2014
- Thrombolysis for Acute Ischemic Stroke in Patients With CancerStroke, 2013
- Off‐label intravenous thrombolysis in acute strokeEuropean Journal of Neurology, 2011
- Recombinant Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the United StatesStroke, 2011
- Risk of Thrombolytic Therapy for Acute Ischemic Stroke in Patients With Current MalignancyJournal of Stroke and Cerebrovascular Diseases, 2011
- Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic StrokeNew England Journal of Medicine, 2008
- Ischemic stroke in patients with primary brain tumorsNeurology, 2008
- Comparison of the Elixhauser and Charlson/Deyo Methods of Comorbidity Measurement in Administrative DataMedical Care, 2004
- Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)The Lancet, 1998
- Comparison of Neurological Scales and Scoring Systems for Acute Stroke PrognosisStroke, 1996